These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 29351761)

  • 1. Selective serotonin reuptake inhibitor use and breast cancer survival: a population-based cohort study.
    Busby J; Mills K; Zhang SD; Liberante FG; Cardwell CR
    Breast Cancer Res; 2018 Jan; 20(1):4. PubMed ID: 29351761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of selective serotonin reuptake inhibitors use on endocrine therapy adherence and breast cancer mortality: a population-based study.
    Valachis A; Garmo H; Weinman J; Fredriksson I; Ahlgren J; Sund M; Holmberg L
    Breast Cancer Res Treat; 2016 Sep; 159(2):293-303. PubMed ID: 27492739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective serotonin reuptake inhibitors associated with increased mortality risk in breast cancer patients in Northern Israel.
    Fischer A; Rennert HS; Rennert G
    Int J Epidemiol; 2022 Jun; 51(3):807-816. PubMed ID: 35134960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective serotonin reuptake inhibitor treatment and depression are associated with poststroke mortality.
    Ried LD; Jia H; Feng H; Cameon R; Wang X; Tueth M; Wu SS
    Ann Pharmacother; 2011 Jul; 45(7-8):888-97. PubMed ID: 21750310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective Serotonin Reuptake Inhibitor Use and Risk of Arrhythmia: A Nationwide, Population-Based Cohort Study.
    Lin YT; Lu TS; Hansen RA; Wang CC
    Clin Ther; 2019 Jun; 41(6):1128-1138.e8. PubMed ID: 31178037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of mortality with concomitant use of tamoxifen and selective serotonin reuptake inhibitors: multi-database cohort study.
    Donneyong MM; Bykov K; Bosco-Levy P; Dong YH; Levin R; Gagne JJ
    BMJ; 2016 Sep; 354():i5014. PubMed ID: 27694571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast cancer recurrence risk related to concurrent use of SSRI antidepressants and tamoxifen.
    Lash TL; Cronin-Fenton D; Ahern TP; Rosenberg CL; Lunetta KL; Silliman RA; Hamilton-Dutoit S; Garne JP; Ewertz M; Sørensen HT; Pedersen L
    Acta Oncol; 2010 Apr; 49(3):305-12. PubMed ID: 20156115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between use of selective serotonin reuptake inhibitors and irritable bowel syndrome: A population-based cohort study.
    Lin WT; Liao YJ; Peng YC; Chang CH; Lin CH; Yeh HZ; Chang CS
    World J Gastroenterol; 2017 May; 23(19):3513-3521. PubMed ID: 28596687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacy and medical costs associated with switching between venlafaxine and SSRI antidepressant therapy for the treatment of major depressive disorder.
    Khandker RK; Kruzikas DT; McLaughlin TP
    J Manag Care Pharm; 2008 Jun; 14(5):426-41. PubMed ID: 18597572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serotonin-norepinephrine reuptake inhibitor and selective serotonin reuptake inhibitor use and risk of fractures: a new-user cohort study among US adults aged 50 years and older.
    Lanteigne A; Sheu YH; Stürmer T; Pate V; Azrael D; Swanson SA; Miller M
    CNS Drugs; 2015 Mar; 29(3):245-52. PubMed ID: 25708711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of Fractures With Concomitant Use of Calcium Channel Blockers and Selective Serotonin Reuptake Inhibitors.
    Desai R; Smith SM; Mohandas R; Brown J; Park H
    Ann Pharmacother; 2024 Sep; 58(9):886-895. PubMed ID: 38078408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perioperative Inpatient Use of Selective Serotonin Reuptake Inhibitors Is Associated With a Reduced Risk of THA and TKA Revision.
    Yao JJ; Maradit Kremers H; Kremers WK; Lewallen DG; Berry DJ
    Clin Orthop Relat Res; 2018 Jun; 476(6):1191-1197. PubMed ID: 29432263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective serotonin reuptake inhibitors and risk of acute pancreatitis: a population-based case-control study.
    Nørgaard M; Jacobsen J; Gasse C; Pedersen L; Mortensen PB; Sørensen HT
    J Clin Psychopharmacol; 2007 Jun; 27(3):259-62. PubMed ID: 17502772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective serotonin reuptake inhibitors use and hepatocellular carcinoma in patients with alcohol use disorder.
    Chen VC; Lee MJ; Yang YH; Lu ML; Chiu WC; Dewey ME
    Drug Alcohol Depend; 2021 Feb; 219():108495. PubMed ID: 33429293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the effects of serotonin-norepinephrine reuptake inhibitors versus selective serotonin reuptake inhibitors on cerebrovascular events.
    Lee YC; Lin CH; Lin MS; Lu Y; Chang CH; Lin JW
    J Clin Psychiatry; 2016 Jan; 77(1):e1-7. PubMed ID: 26845272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risks of hospitalization for upper gastrointestinal bleeding in users of selective serotonin reuptake inhibitors after Helicobacter pylori eradication therapy: a propensity score matching analysis.
    Guo CG; Cheung KS; Zhang F; Chan EW; Chen L; Wong ICK; Leung WK
    Aliment Pharmacol Ther; 2019 Nov; 50(9):1001-1008. PubMed ID: 31583734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between selective serotonin reuptake inhibitor use and developing irritable bowel syndrome through retrospective analysis.
    Kwak N; Lee H; Kim BK; Yu YM; Kang HY
    J Gastroenterol Hepatol; 2024 Feb; 39(2):280-288. PubMed ID: 37961007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A population-based case-control study of Selective Serotonin Reuptake Inhibitors (SSRIs) and breast cancer: the impact of duration of use, cumulative dose and latency.
    Ashbury JE; Lévesque LE; Beck PA; Aronson KJ
    BMC Med; 2010 Dec; 8():90. PubMed ID: 21176215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Selective Serotonin Reuptake Inhibitor Use and Acute Angle-Closure Glaucoma.
    Chen HY; Lin CL; Lai SW; Kao CH
    J Clin Psychiatry; 2016 Jun; 77(6):e692-6. PubMed ID: 27135704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Selective Serotonin Reuptake Inhibitors With the Risk for Spontaneous Intracranial Hemorrhage.
    Renoux C; Vahey S; Dell'Aniello S; Boivin JF
    JAMA Neurol; 2017 Feb; 74(2):173-180. PubMed ID: 27918771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.